US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Orexo AB

2.60

0.0000

Volume:- -

Turnover:- -

Market Cap:89.71M

PE:-4.19

High:2.60

Open:2.60

Low:2.60

Close:2.60

52wk High:4.05

52wk Low:1.48

Shares:34.51M

Float Shares:70.00

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.6207

ROE:-221.41%

ROA:-23.25%

PB:1.63

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Orexo AB

Exchange:

OTCQX

Establishment Date:

1994

Employees:

72

Office Location:

Rapsgatan 7E,Uppsala,Uppsala County,Sweden

Website:

http://www.orexo.com

Zip Code:

- -

Phone:

46 1 87 80 88 00

Fax:

46 1 87 80 88 88

Introduction:

Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 for emergency treatment of allergic reactions; and OX-MPI for the treatment of endometriosis. In addition, its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ORXOY/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ORXOY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ORXOY\",,,,,undefined,":{"symbol":"ORXOY","market":"US","secType":"STK","nameCN":"Orexo AB","latestPrice":2.6,"timestamp":1770842340000,"preClose":2.6,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":70,"shares":34505226,"eps":-0.6207,"marketStatus":"Trading","change":0,"latestTime":"02-11 15:39:00 EST Delay","open":2.6,"high":2.6,"low":2.6,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.6207,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1770843600000},"marketStatusCode":2,"adr":0,"adrRate":1,"exchange":"OTCQX","adjPreClose":2.6,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ORXOY\",,,,,undefined,":{"symbol":"ORXOY","floatShares":70,"roa":"-23.25%","roe":"-221.41%","lyrEps":0,"shares":34505226,"dividePrice":0,"high":2.6,"amplitude":0,"preClose":2.6,"low":2.6,"week52Low":1.475,"pbRate":"1.63","psRate":"30.69","week52High":4.05,"institutionHeld":0,"latestPrice":2.6,"eps":-0.6207,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.6207,"open":2.6,"prevYearClose":2.6,"prevWeekClose":2.6,"prevMonthClose":2.6,"prevQuarterClose":2.6,"fiveDayClose":2.6,"twentyDayClose":2.6,"sixtyDayClose":2.9},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ORXOY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-06","symbol":"ORXOY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1738818000000,"reportTimeType":"","actualEps":null},{"date":"2024-07-17","symbol":"ORXOY","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1721203200000,"name":null,"time":"","dateTimestamp":1721188800000,"actualEps":null},{"date":"2024-05-08","symbol":"ORXOY","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715155200000,"name":null,"time":"","dateTimestamp":1715140800000,"actualEps":null},{"market":"US","date":"2022-11-03","symbol":"ORXOY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1667448000000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ORXOY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ORXOY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1582002000000},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":6021724,"yearFounded":1994,"employeeNum":72,"address":"Rapsgatan 7E,Uppsala,Uppsala County,Sweden","officePhone":"46 1 87 80 88 00","officeFax":"46 1 87 80 88 88"},"stockCompanyDetail":{"websiteUrl":"http://www.orexo.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.0044},{"period":"3month","weight":-0.3212},{"period":"6month","weight":-0.3},{"period":"1year","weight":-0.1765},{"period":"ytd","weight":-0.104}],"description":"Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 for emergency treatment of allergic reactions; and OX-MPI for the treatment of endometriosis. In addition, its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.","exchange":"OTCQX","name":"Orexo AB","nameEN":"Orexo AB"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ORXOY\",market:\"US\",,,undefined,":null}}